A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
- First Posted Date
- 2022-01-21
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 228
- Registration Number
- NCT05201781
- Locations
- 🇨🇳
First Hospital, Zhejiang University Medical College, Hangzhou, China
🇨🇳Jiangsu Province Hospital, Nanjing, China
🇨🇳Ruijin Hospital Shanghai Jiao Tong University, Shanghai, China
A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease
- Conditions
- Interventions
- First Posted Date
- 2022-01-19
- Last Posted Date
- 2024-10-29
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 350
- Registration Number
- NCT05197049
- Locations
- 🇧🇷
Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto Hospital de Base, Sao Jose do Rio Preto, Brazil
🇺🇸Digestive Health Specialists of the Southeast, Dothan, Alabama, United States
🇺🇸Advanced Gastro P.C, Chandler, Arizona, United States
A Study to Assess the Acceptability of the Darunavir/Cobicistat (DRV/COBI) Fixed-dose Combination (FDC) Tablet in Human Immunodeficiency Virus (HIV)-1 Infected Children
- First Posted Date
- 2022-01-19
- Last Posted Date
- 2023-09-14
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 15
- Registration Number
- NCT05197075
- Locations
- 🇪🇸
Hosp. Gral. Univ. Gregorio Maranon, Madrid, Spain
🇿🇦Global Clinical Trials PE, Pretoria, South Africa
🇺🇸Emory University, Atlanta, Georgia, United States
A Study of 14C JNJ-67953964 in Healthy Adult Male Participants
- First Posted Date
- 2022-01-19
- Last Posted Date
- 2022-04-29
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 8
- Registration Number
- NCT05197062
- Locations
- 🇳🇱
PRA Health Sciences, Groningen, Netherlands
A Study of Pentosan Polysulfate Sodium and the Development of Pigmentary Maculopathy and Pigmentary Retinopathy
- Conditions
- First Posted Date
- 2022-01-05
- Last Posted Date
- 2023-12-14
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 2
- Registration Number
- NCT05179460
- Locations
- 🇺🇸
Janssen R&D, LLC, Titusville, New Jersey, United States
Pre-approval Access Single Patient Request for Teclistamab (JNJ-64007957)
- Conditions
- First Posted Date
- 2021-12-17
- Last Posted Date
- 2022-08-16
- Lead Sponsor
- Janssen Research & Development, LLC
- Registration Number
- NCT05161598
A Study in Healthy Adult Participants to Assess the Effects of Ciclosporin Administration on Rilematovir
- First Posted Date
- 2021-12-13
- Last Posted Date
- 2022-02-17
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 18
- Registration Number
- NCT05155007
- Locations
- 🇧🇪
Clinical Pharmacology Unit, Merksem, Belgium
A Study of JNJ-80202135 in Healthy Chinese Adult Participants
- First Posted Date
- 2021-12-09
- Last Posted Date
- 2022-10-26
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 30
- Registration Number
- NCT05151692
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, China
A Study of Acute Respiratory Infections in Global Outpatient Setting
- Conditions
- Interventions
- First Posted Date
- 2021-12-08
- Last Posted Date
- 2024-08-02
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 245
- Registration Number
- NCT05148780
- Locations
- 🇺🇸
Harrisburg Family Medical Center, Harrisburg, Arkansas, United States
🇺🇸Innovative Research of West Florida, Incorporated, Clearwater, Florida, United States
🇺🇸New Life Medical Research Center, Inc., Hialeah, Florida, United States
A Study of JNJ-73763989, JNJ-64300535, and Nucleos(t)Ide Analogs in Virologically Suppressed, Hepatitis B e Antigen (HBeAg)- Negative Participants With Chronic Hepatitis B Virus Infection
- Conditions
- Interventions
- First Posted Date
- 2021-11-17
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 24
- Registration Number
- NCT05123599
- Locations
- 🇮🇹
Irccs Ospedale Maggiore Di Milano, Milano, Italy
🇳🇿New Zealand Clinical Research, Auckland, New Zealand
🇵🇱ID Clinic, Myslowice, Poland